Roland Zahn

6.8k total citations
59 papers, 1.3k citations indexed

About

Roland Zahn is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Roland Zahn has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 28 papers in Infectious Diseases and 15 papers in Immunology. Recurrent topics in Roland Zahn's work include Respiratory viral infections research (14 papers), Viral gastroenteritis research and epidemiology (13 papers) and Virus-based gene therapy research (12 papers). Roland Zahn is often cited by papers focused on Respiratory viral infections research (14 papers), Viral gastroenteritis research and epidemiology (13 papers) and Virus-based gene therapy research (12 papers). Roland Zahn collaborates with scholars based in Netherlands, United States and Germany. Roland Zahn's co-authors include Hanneke Schuitemaker, Thomas Brinkmann, C Götting, Joachim Kühn, K Kleesiek, Lies Bogaert, Johannes P. M. Langedijk, Myra N. Widjojoatmodjo, Jason S. McLellan and Pascale Bouchier and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Roland Zahn

58 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roland Zahn Netherlands 20 568 519 364 261 206 59 1.3k
Cyril Empig United States 12 302 0.5× 347 0.7× 560 1.5× 589 2.3× 94 0.5× 15 1.4k
Yonghe Qi China 15 2.3k 4.0× 631 1.2× 560 1.5× 358 1.4× 136 0.7× 18 3.0k
Patrick Hong United States 12 247 0.4× 171 0.3× 303 0.8× 337 1.3× 143 0.7× 17 832
Michael J. McGarvey United Kingdom 18 1.6k 2.8× 250 0.5× 325 0.9× 135 0.5× 105 0.5× 33 1.9k
Thomas Günther Germany 19 448 0.8× 228 0.4× 292 0.8× 133 0.5× 88 0.4× 46 1.2k
M. Ohuchi Japan 17 581 1.0× 184 0.4× 226 0.6× 143 0.5× 125 0.6× 24 959
Julie Lucifora France 27 1.8k 3.2× 388 0.7× 434 1.2× 491 1.9× 117 0.6× 63 2.3k
Puck B. van Kasteren Netherlands 15 214 0.4× 451 0.9× 300 0.8× 355 1.4× 120 0.6× 32 1.0k
Maria Blasi United States 16 196 0.3× 266 0.5× 305 0.8× 263 1.0× 135 0.7× 35 884
Richard Janeczko United States 15 568 1.0× 266 0.5× 277 0.8× 35 0.1× 193 0.9× 18 1.0k

Countries citing papers authored by Roland Zahn

Since Specialization
Citations

This map shows the geographic impact of Roland Zahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Zahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Zahn more than expected).

Fields of papers citing papers by Roland Zahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Zahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Zahn. The network helps show where Roland Zahn may publish in the future.

Co-authorship network of co-authors of Roland Zahn

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Zahn. A scholar is included among the top collaborators of Roland Zahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Zahn. Roland Zahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bakkers, Mark J. G., Tina Ritschel, Machteld M. Tiemessen, et al.. (2024). Efficacious human metapneumovirus vaccine based on AI-guided engineering of a closed prefusion trimer. Nature Communications. 15(1). 6270–6270. 13 indexed citations
2.
Martinot, Amanda J., Freek Cox, Peter Abbink, et al.. (2024). Ad26.M.Env ZIKV vaccine protects pregnant rhesus macaques and fetuses against Zika virus infection. npj Vaccines. 9(1). 157–157. 1 indexed citations
3.
Langedijk, Johannes P. M., Freek Cox, Nicole V. Johnson, et al.. (2024). Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein. Nature Communications. 15(1). 4629–4629. 4 indexed citations
4.
Verspuij, Johan, Mark A. Findeis, Angela Hafner, et al.. (2024). Plant Cell Culture-Derived Saponin Adjuvant Enhances Immune Response Against a Stabilized Human Metapneumovirus Pre-Fusion Vaccine Candidate. Vaccines. 12(12). 1435–1435. 5 indexed citations
5.
Bakkers, Mark J. G., Freek Cox, Annemart Koornneef, et al.. (2024). A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses. Nature Microbiology. 9(12). 3254–3267. 7 indexed citations
6.
Koornneef, Annemart, Kanika Vanshylla, Gijs Hardenberg, et al.. (2024). CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits. Nature Communications. 15(1). 3128–3128. 4 indexed citations
7.
8.
Saeland, Eiríkur, Leslie van der Fits, Lisanne Tettero, et al.. (2023). Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models. npj Vaccines. 8(1). 45–45. 11 indexed citations
9.
10.
Wang, Jing Jing, Marijn van der Neut Kolfschoten, Lucy Rutten, et al.. (2023). Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT. Blood. 143(4). 370–374. 6 indexed citations
11.
Wang, Jenny, Marijn van der Neut Kolfschoten, Lucy Rutten, et al.. (2023). OC 55.4 Recombinant Human anti-PF4 IgGs Regenerated from VITT Sera Activate Platelets and Endothelial Cells. Research and Practice in Thrombosis and Haemostasis. 7. 100494–100494. 1 indexed citations
12.
13.
Mahrokhian, Shant H., Lisa H. Tostanoski, Catherine Jacob-Dolan, et al.. (2022). Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice. npj Vaccines. 7(1). 23–23. 6 indexed citations
14.
Bockstal, Viki, Maarten Leyssen, Dirk Heerwegh, et al.. (2022). Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola. npj Vaccines. 7(1). 156–156. 13 indexed citations
15.
Hoogen, Bernadette van den, Angela Santoni, Giuseppe Sciumè, et al.. (2020). Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network. Virus Research. 287. 198094–198094. 2 indexed citations
16.
Serroyen, Jan, et al.. (2019). Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations. npj Vaccines. 4(1). 54–54. 19 indexed citations
17.
Vujadinovic, Marija, Selina Khan, Koen Oosterhuis, et al.. (2018). Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses. Vaccine. 36(30). 4462–4470. 18 indexed citations
18.
Bockstal, Viki, Taco G. Uil, Yutong Song, et al.. (2016). Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine. PLoS Pathogens. 12(3). e1005483–e1005483. 23 indexed citations
19.
Keating, Sheila M., John W. Heitman, Shiquan Wu, et al.. (2016). Magnitude and Quality of Cytokine and Chemokine Storm during Acute Infection Distinguish Nonprogressive and Progressive Simian Immunodeficiency Virus Infections of Nonhuman Primates. Journal of Virology. 90(22). 10339–10350. 23 indexed citations
20.
Zahn, Roland, Felix G. Hermann, Eun‐Young Kim, et al.. (2008). Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides. Gene Therapy. 15(17). 1210–1222. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cyril Empig Breakdown of academic impact, for papers by Yonghe Qi Breakdown of academic impact, for papers by Patrick Hong Breakdown of academic impact, for papers by Michael J. McGarvey Breakdown of academic impact, for papers by Thomas Günther Breakdown of academic impact, for papers by M. Ohuchi Breakdown of academic impact, for papers by Julie Lucifora Breakdown of academic impact, for papers by Puck B. van Kasteren Breakdown of academic impact, for papers by Maria Blasi Breakdown of academic impact, for papers by Richard Janeczko
Rankless by CCL
2026